Intralesional amphotericin B in a cat with refractory localised sporotrichosis

J Feline Med Surg. 2009 Aug;11(8):720-3. doi: 10.1016/j.jfms.2009.01.012. Epub 2009 Jun 23.

Abstract

The present report concerns a case of sporotrichosis in a 3-year-old male crossbred cat. After 9 months of oral itraconazole (20mg/kg) therapy, all skin lesions had resolved with the exception of a single nodular lesion located on the bridge of the nose. Therefore, a combined therapy that included intralesional (IL) amphotericin B (1mg/kg) was started. The lesion resolved completely after three weekly administrations of IL amphotericin B, given in concert with oral itraconazole. The cat remains well 1 year after discontinuing therapy, with no signs of recurrence.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / administration & dosage*
  • Animals
  • Antifungal Agents / administration & dosage*
  • Brazil
  • Cat Diseases / drug therapy*
  • Cat Diseases / microbiology
  • Cats
  • Injections, Intralesional / veterinary
  • Male
  • Nose Diseases / drug therapy
  • Nose Diseases / microbiology
  • Nose Diseases / veterinary
  • Sporotrichosis / drug therapy
  • Sporotrichosis / veterinary*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Amphotericin B